Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Negative feedback is a crucial physiological regulatory mechanism, but no such regulator of angiogenesis has been established. Here we report a novel angiogenesis inhibitor that is induced in endothelial cells (ECs) by angiogenic factors and inhibits angiogenesis in an autocrine manner. We have performed cDNA microarray analysis to survey VEGF-inducible genes in human ECs. We characterized one such gene, KIAA1036, whose function had been uncharacterized. The recombinant protein inhibited migration, proliferation, and network formation by ECs as well as angiogenesis in vivo. This inhibitory effect was selective to ECs, as the protein did not affect the migration of smooth muscle cells or fibroblasts. Specific elimination of the expression of KIAA1036 in ECs restored their responsiveness to a higher concentration of VEGF. The expression of KIAA1036 was selective to ECs, and hypoxia or TNF-alpha abrogated its inducible expression. As this molecule is preferentially expressed in ECs, we designated it "vasohibin." Transfection of Lewis lung carcinoma cells with the vasohibin gene did not affect the proliferation of cancer cells in vitro, but did inhibit tumor growth and tumor angiogenesis in vivo. We propose vasohibin to be an endothelium-derived negative feedback regulator of angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 3×
“Nevertheless, it is well known that tumors are associated with hypoxia as well as the infiltration of inflammatory cells (22, 23).”
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“Although angiopoietin-1 and angiopoietin-2 can be classified as either angiogenic factors or angiogenesis inhibitors, the main function of angiopoietins is to regulate mural cell attachment for vascular stabilization (14).”
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Role of angiogenesis in tumor growth and metastasis
Folkman, J. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37263 · Cited by 2,404
VEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536 · cited 1×
“It is induced by hypoxia and stimulates the migration and proliferation of endothelial cells (ECs) (3).”
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H.-J., Benedict, W., & Bouck, N. P. (1999) · Science · doi:10.1126/science.285.5425.245 · Cited by 1,505
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., & Bouck, N. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,054
Structure and mechanism of interleukin-lβ converting enzyme
Wilson, K. P., Black, J.-A. F., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko, M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A., et al. (1994) · Nature · doi:10.1038/370270a0 · Cited by 847
Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 697
PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activity
Tombran-Tink, J., Chader, G. G., & Johnson, L. V. (1991) · Experimental Eye Research · doi:10.1016/0014-4835(91)90248-d · Cited by 574
Pigment epithelium–derived factor regulates the vasculature and mass of the prostate and pancreas
Doll, J. A., Stellmach, V. M., Bouck, N. P., Bergh, A. R., Lee, C., Abramson, L. P., Cornwell, M. L., Pins, M. R., Borensztajn, J., & Crawford, S. E. (2003) · Nature Medicine · doi:10.1038/nm870 · Cited by 289
Strieter, R. M., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., & Polverini, P. J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1626 · Cited by 287
Kanno, S., Oda, N., Abe, M., Terai, Y., Ito, M., Shitara, K., Tabayashi, K., Shibuya, M., & Sato, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203533 · Cited by 285
Self-citationKobayashi, Y., Yamamoto, K., Saido, T., Kawasaki, H., Oppenheim, J. J., & Matsushima, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5548 · Cited by 278
Iwasaka, C., Tanaka, K., Abe, M., & Sato, Y. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199612)169:3<522::aid-jcp12>3.0.co;2-7 · Cited by 278
Self-citationFERRARA, N., CLAPP, C., & WEINER, R. (1991) · Endocrinology · doi:10.1210/endo-129-2-896 · Cited by 212
Hypoxia Induces Transcription Factor ETS-1 via the Activity of Hypoxia-Inducible Factor-1
Oikawa, M., Abe, M., Kurosawa, H., Hida, W., Shirato, K., & Sato, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5927 · Cited by 161
Self-citationAbé, M., & Sato, Y. (2001) · Angiogenesis · doi:10.1023/a:1016018617152 · Cited by 138
Self-citationCao, Y., Chen, C., Weatherbee, J. A., Tsang, M., & Folkman, J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.2069 · Cited by 135
The discovery of angiogenic factors:
Ribatti, D., Vacca, A., & Presta, M. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(01)00112-4 · Cited by 117
The Role of Thrombospondin-1 in Tumor Progression
Sargiannidou, I., Zhou, J., & Tuszynski, G. P. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020222600803 · Cited by 106
One-Step Direct Assay for Mature-type Adrenomedullin with Monoclonal Antibodies
Ohta, H., Tsuji, T., Asai, S., Sasakura, K., Teraoka, H., Kitamura, K., & Kangawa, K. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.2.244 · Cited by 95
Self-citationSelective release of a processed form of interleukin 1α
Watanabe, N., & Kobayashi, Y. (1994) · Cytokine · doi:10.1016/1043-4666(94)90046-9 · Cited by 70
Miyashita, H., Yamazaki, T., Akada, T., Niizeki, O., Ogawa, M., Nishikawa, S.-I., & Sato, Y. (2002) · Blood · doi:10.1182/blood.v99.9.3241 · Cited by 65
Self-citationFeedback regulators in normal and tumour tissues
Lord, B. I. (1988) · Journal of Cell Science · doi:10.1242/jcs.1988.supplement_10.16 · Cited by 15
Use of Adenovirus Vectors for Functional Gene Analysis in the Chicken Chorioallantoic Membrane
Schughart, K., & Accart, N. (2003) · BioTechniques · doi:10.2144/03341dd06 · Cited by 4
Research works printed but not linked: 4
Cited by
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
“The most recently described endogenous inhibitor of angiogenesis is vasohibin, which seems to be derived from the endothelium and to operate as a feedback regulato”
BackgroundKerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Takahashi, H., & Shibuya, M. (2005) · Clinical Science · doi:10.1042/cs20040370 · Cited by 953
Regulation of Tumor Angiogenesis by EZH2
Lu, C., Han, H. D., Mangala, L. S., Ali-Fehmi, R., Newton, C. S., Ozbun, L., Armaiz-Pena, G. N., Hu, W., Stone, R. L., Munkarah, A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.016 · Cited by 399
Metadata
- Authors
- Watanabe, K., Hasegawa, Y., Yamashita, H., Shimizu, K., Ding, Y., Abe, M., Ohta, H., Imagawa, K., Hojo, K., Maki, H., Sonoda, H., & Sato, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-10-01
- Volume
- 114
- Issue
- 7
- Pages
- 898-907
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4249769808
- Cited by
- 317
- References
- 30
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.